Maximal response plateau to adenosine 5′-monophosphate in asthma

Chest

Volumn 135, Issue 6, 2009, Pages 1521-1526

  Prieto, Luis ^a,d   Esnal, Saioa ^b   Lopez, Victoria ^a   Barato, Desire ^a   Rojas, Rocio ^a   Marín, Julio ^c  

^a Asociacion Valenciana de Investigaciones Clinicas   (Spain)

^b HOSPITAL TXAGORRITXU   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Adenosine 5 monophosphate; Airway responsiveness; Asthma; Exhaled breath condensate; Methacholine; Nitric oxide; pH; Plateau

Indexed keywords

ADENOSINE PHOSPHATE; METHACHOLINE; NITRIC OXIDE;

ADULT; ARTICLE; ASTHMA; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PH; PREVALENCE; PRIORITY JOURNAL; RELIABILITY; RESPIRATORY TRACT INFLAMMATION;

EID: 66649118869     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2392     Document Type: Article

References (40)

1. Cockcroft DW, Killian DN, Mellon JJ, et al. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Exp Allergy 1977; 7:235-243 (Pubitemid 8159924)
2. Avital A, Springer Ch, Bar-Yishag E, et al. Adenosine, methacholine and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease. Thorax 1995; 50:511-516
3. Polosa R, Ng WH, Crimi N, et al. Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. Am J Respir Crit Care Med 1995; 151:624-629
4. Van Schoor J, Joos GF, Kips TC, et al. The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise-and adenosine-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 1997; 155:875-880 (Pubitemid 27133397)
5. Woolcock AJ. What is bronchial hyperresponsiveness from the clinical standpoint? In: Page CP, Gardiner PJ, eds. Airway hyperresponsiveness: is it really important for asthma? Oxford, UK: Blackwell Scientific Publications, 1993; 1-9
6. Woolcock AJ, Salome CM, Yan K. The shape of the dose-response curve to histamine in asthmatic and normal subjects. Am Rev Respir Dis 1984; 130:71-75 (Pubitemid 14092984)
7. Sterk PJ, Bel EH. Bronchial hyperresponsiveness: the need for a distinction between hypersensitivity and excessive airway narrowing. Eur Respir J 1989; 2:267-274 (Pubitemid 19107110)
8. Bel EH, Timmers MC, Zwinderman AH, et al. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects. Am Rev Respir Dis 1991; 143:109-113
9. Sont JK, Bel EH, Dijkman JH, et al. The long-term effect on nedocromil sodium on the maximal degree of airway narrowing to methacholine in atopic asthmatic subjects. Clin Exp Allergy 1992; 22:554-560
10. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6:1368-1370 (Pubitemid 23329557)
11. Karitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343:133-135 (Pubitemid 24028638)
12. Hunt JP, Pang K, Malik R, et al. Endogenous airway modification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000; 161:694-699 (Pubitemid 30171718)
13. Kostikas K, Papatheodorou G, Ganas K, et al. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002; 165:1364-1370 (Pubitemid 34522938)
14. Jatakanon A, Lim S, Kharitonov SA, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53:91-95 (Pubitemid 28212132)
15. Barnes PJ, Kharitonov SA. Exhaled nitric oxide: a new lung function test. Thorax 1996; 51:233-237 (Pubitemid 26086466)
16. Kostikas K, Koutsokera A, Papiris S, et al. Exhaled breath condensate in patients with asthma: implications for application in clinical practice. Clin Exp Allergy 2008; 38:557-565
17. Van den Toorn LM, Prins JP, Overbeek SE, et al. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000; 162:953-957
18. Prieto L, Gutierrez V, UIxera S, et al. Concentrations of exhaled nitric oxide in asthmatics and subjects with allergic rhinitis sensitized to the same pollen allergen. Clin Exp Allergy 2002; 32:1728-1733 (Pubitemid 35463857)
19. American Thoracic Society. Standardization of spirometry, 1987 update. Am Rev Respir Dis 1987; 136:1285-1298
20. Chai H, Farr RS, Froehlich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56:323-327
21. American Thoracic Society. Guidelines for methacholine and exercise challenge testing, 1999. Am J Respir Crit Care Med 2000; 161:309-329
22. Prieto L, Berto JM, Lopez M, et al. Modifications of PC20 and maximal degree of airway narrowing to methacholine after pollen season in pollen sensitive asthmatic patients. Clin Exp Allergy 1993; 23:172-178 (Pubitemid 23112338)
23. Prieto L, Lopez M, Berto JM, et al. Modification of concentration- response curves to inhaled methacholine after the pollen season in subjects with pollen induced rhinitis. Thorax 1994; 49:711-713 (Pubitemid 24219153)
24. American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005; 171:912-930 (Pubitemid 40562723)
25. Prieto L, Bruno L, Gutierrez V, et al. Airway responsiveness to adenosine 5′monophosphate and exhaled nitric oxide measurements. Predictive value as markers for reducing the dose of inhaled corticosteroids in asthmatic subjects. Chest 2003; 124:1325-1333
26. Prieto L, Gutierrez V, Perez-Frances C, et al. Effect of fluticasone propionate-salmeterol therapy on seasonal changes in airway responsiveness and exhaled nitric oxide levels in patients with pollen-induced asthma. Ann Allergy Asthma Immunol 2005; 95:452-461 (Pubitemid 41688507)
27. Prieto L, Ferrer A, Palop J, et al. Differences in exhaled breath condensate pH measurements between samples obtained with two commercial devices. Respir Med 2007; 101:1715-1720 (Pubitemid 46930710)
28. Vaughan J, Ngamtrakalpanit L, Pajewski TN, et al. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J 2003; 22:889-894 (Pubitemid 37540637)
29. Sterk PJ, Daniel EF, Zamel N, et al. Limited bronchoconstriction to methacholine using partial flow-volume curves in asthmatic subjects. Am Rev Respir Dis 1985; 132:272-277 (Pubitemid 15229379)
30. Prieto L, Gutierrez V, Liñana J, et al. Bronchoconstriction induced by inhaled adenosine 5′-monophosphate in subjects with allergic rhinitis. Eur Respir J 2001; 17:64-70 (Pubitemid 32600558)
31. Prieto L, Gutierrez V, Marin J. Relationship between airway sensitivity to adenosine 5′-monophosphate and the shape of the concentration-response curve to methacholine in subjects with allergic rhinitis. Respir Med 2001; 95:457-463 (Pubitemid 32621998)
32. Prieto L, Seijas T, Gutierrez V, et al. Exhaled nitric oxide levels and airway responsiveness to adenosine 5′-monophosphate in subjects with nasal polyposis. Int Arch Allergy Immunol 2004; 134:302-309 (Pubitemid 39070164)
33. Pauwels R, Joos G, van der Straeten M. Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma. Clin Allergy 1998; 18:317-321 (Pubitemid 18179371)
34. O'Connor BJ, Ridge SM, Barnes PJ, et al. Greater effect of inhaled budesonide on adenosine 5′-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma. Am Rev Respir Dis 1992; 146:560-564
35. Van Velzen E, van den Bos JW, Benckhuijsen JA, et al. Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax 1996; 51:582-584 (Pubitemid 26226510)
36. Polosa R, Lau LCK, Holgate ST. Inhibition of adenosine 5′-monophosphate-and methacholine-induced bronchoconstriction in asthma by inhaled frusemide. Eur Respir J 1990; 3:665-671 (Pubitemid 20228705)
37. Möller GM, Overbeek SE, Van Helden-Meeuwsen CG, et al. Eosinophils in the bronchial mucosa in relation to methacholine dose-response curves in atopic asthma. J Appl Physiol 1999; 86:1352-1356 (Pubitemid 29172171)
38. 2 partial pressure. Eur Respir J 2007; 29:496-501
39. Kullmann T, Barta I, Antas B, et al. Environmental temperature and relative humidity influence exhaled breath condensate pH. Eur Respir J 2008; 31:474-475
40. Effros RM, Casaburi R, Su J, et al. The effects of volatile salivary acids and bases upon exhaled breath condensate pH. Am J Respir Crit Care Med 2006; 173:386-392 (Pubitemid 43228325)